Park Place Capital’s Chemed CHE Stock Holding History

Park Place Capital’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.17M	Buy	4,668 +218	+5%	+$91.7K	0.35%	50
2026 Q1	$1.68M	Buy	4,450 +1,173	+36%	+$502K	0.34%	47
2025 Q4	$1.4M	Sell	3,277 -337	-9%	-$147K	0.29%	58
2025 Q3	$1.62M	Buy	3,614 +114	+3%	+$51.6K	0.34%	51
2025 Q2	$1.69M	Sell	3,500 -72	-2%	-$41K	0.39%	48
2025 Q1	$2.2M	Buy	3,572 +1,486	+71%	+$845K	0.6%	32
2024 Q4	$1.11M	Buy	2,086 +522	+33%	+$294K	0.31%	73
2024 Q3	$940K	Buy	1,564 +484	+45%	+$274K	0.27%	85
2024 Q2	$586K	Buy	1,080 +680	+170%	+$389K	0.19%	114
2024 Q1	$257K	Buy	400 +351	+716%	+$213K	0.09%	203
2023 Q4	$28.7K	Hold	49	–	–	0.01%	481
2023 Q3	$25.5K	Hold	49	–	–	0.01%	585
2023 Q2	$26.5K	Hold	49	–	–	0.01%	601
2023 Q1	$26.4K	Hold	49	–	–	0.01%	595
2022 Q4	$25K	Buy	+49	New	+$23.9K	0.01%	609

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Park Place Capital's CHE Position: Q2 2026 in Review

Park Place Capital increased its Chemed (CHE) stake by 4.9% in Q2 2026, buying an estimated $91.7K and bringing the position to 4,668 shares worth $2.17M. The position accounts for 0.35% of the portfolio, ranked #50.

Park Place Capital first reported a position in CHE in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.2M in Q1 2025. 531 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Park Place Capital held 4,668 shares of Chemed worth $2.17M as of Q2 2026.
Park Place Capital bought 218 Chemed shares in Q2 2026, an estimated $91.7K.
Chemed made up 0.35% of Park Place Capital's portfolio in Q2 2026, its #50 holding.
Park Place Capital first reported a position in Chemed in Q4 2022 and has held it in 15 quarters since.
Park Place Capital's Chemed position peaked at $2.2M in Q1 2025.
531 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.